Clinical Trial Update: MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating MND-ADA transduction of CD34+ cells in children with ADA-SCID has completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Combined Immunodeficiency

Drugs mentioned

• MND-ADA transduction of CD34+ cells

Snippet

Sponsor: Donald B. Kohn, M.D. | Conditions: Severe Combined Immunodeficiency | Phase 2 | Status: COMPLETED | Results posted: 2016-05-30